Fiduciary Alliance LLC Sells 3,951 Shares of Colgate-Palmolive Company $CL

Key Points

• Fiduciary Alliance LLC has reduced its stake in Colgate-Palmolive Company by 8.1%, selling 3,951 shares and now holding 44,959 shares valued at approximately $4.09 million.
• Several hedge funds have recently acquired or increased their positions in Colgate-Palmolive, with a significant increase of 398.6% in holdings from Penserra Capital Management LLC.
• Colgate-Palmolive plans to pay a quarterly dividend of $0.52 per share on November 14, representing an annual yield of 2.5% with a payout ratio of 58.43%.

Fiduciary Alliance LLC lessened its holdings in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 8.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,959 shares of the company's stock after selling 3,951 shares during the period. Fiduciary Alliance LLC's holdings in Colgate-Palmolive were worth $4,087,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Personal CFO Solutions LLC acquired a new position in Colgate-Palmolive during the 1st quarter worth approximately $285,000. Vision Capital Management Inc. acquired a new position in Colgate-Palmolive during the first quarter worth $322,000. Autumn Glory Partners LLC grew its position in Colgate-Palmolive by 67.4% in the first quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock valued at $851,000 after purchasing an additional 3,586 shares in the last quarter. Financial Gravity Asset Management Inc. acquired a new stake in Colgate-Palmolive in the 1st quarter valued at $2,166,000. Finally, Penserra Capital Management LLC lifted its position in Colgate-Palmolive by 398.6% during the 1st quarter. Penserra Capital Management LLC now owns 10,651 shares of the company's stock worth $997,000 after buying an additional 8,515 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CL. JPMorgan Chase & Co. decreased their price target on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a research note on Monday, August 4th. Wells Fargo & Company decreased their target price on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating for the company in a research note on Monday, August 4th. Citigroup dropped their price target on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a research report on Monday, August 4th. Barclays boosted their price objective on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research note on Tuesday, July 15th. Finally, Morgan Stanley dropped their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive currently has an average rating of "Moderate Buy" and a consensus target price of $98.00.

Colgate-Palmolive Stock Down 1.4%

NYSE CL opened at $82.10 on Tuesday. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The company has a market cap of $66.35 billion, a price-to-earnings ratio of 23.06, a PEG ratio of 4.33 and a beta of 0.35. The company has a 50 day moving average of $85.72 and a 200-day moving average of $89.47. Colgate-Palmolive Company has a 1-year low of $81.60 and a 1-year high of $105.92.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping analysts' consensus estimates of $0.89 by $0.03. The firm had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company's revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the company earned $0.91 EPS. On average, equities research analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be given a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.5%. Colgate-Palmolive's dividend payout ratio is currently 58.43%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.